Quotient: Rises as FDA approves emergency use of its COVID-19 antibody test

Quotient

28/09/2020 12:34

** Shares of Switzerland-based diagnostics co  QTNT.O  rise
9.53% to $5.63 premarket
    ** Co gets the U.S. FDA's emergency use authorization for
its COVID-19 antibody test  urn:newsml:reuters.com:*:nGNX4vWVXj
    ** Says test detects antibodies generated in humans in
response to the SARS-CoV-2 virus, using company's proprietary
MosaiQ blood testing microarray technology 
    ** One MosaiQ testing instrument can process up to 3,000
antibody tests per day, says company
    ** Co already has contracts to supply the antibody tests to
customers in the United States
    


 (Reporting by Vishwadha Chander in Bengaluru)
 ((Vishwadha.Chander@thomsonreuters.com; within U.S. +1 646 223
8780, outside U.S. +91 80 6749 6132;))